A randomized, double-blinded, placebo-controlled multicenter phase II trial of adjuvant immunotherapy with tecemotide (L-BLP25) after R0/R1 hepatic colorectal cancer metastasectomy (LICC): Final results.

CC Schimanski; S Kasper; S Hegewisch-Becker; J Schroeder; F Overkamp; F Kullmann; WO Bechstein; M Vohringer; R Oellinger; F Lordick; V Heinemann; M Geissler; A Schulz-Abelius; B Linz; H Bernhard; MR Schoen; Richard Greil; V Smith-Machnow; I Schmidtmann; MH Moehler

doi:10.1200/JCO.2019.37.4_suppl.480

A randomized, double-blinded, placebo-controlled multicenter phase II trial of adjuvant immunotherapy with tecemotide (L-BLP25) after R0/R1 hepatic colorectal cancer metastasectomy (LICC): Final results.

CC Schimanski, S Kasper, S Hegewisch-Becker, J Schroeder, F Overkamp, F Kullmann, WO Bechstein, M Vohringer, R Oellinger, F Lordick, V Heinemann, M Geissler, A Schulz-Abelius, B Linz, H Bernhard, MR Schoen, Richard Greil, V Smith-Machnow, I Schmidtmann, MH Moehler

Department of Internal Medicine III - Division of Hematology, Medical Oncology, Hemostaseology, Rheumatology, Infectiology and Oncologic Center

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Journal	JOURNAL OF CLINICAL ONCOLOGY
Volume	37
Issue number	4
DOIs	https://doi.org/10.1200/JCO.2019.37.4_suppl.480
Publication status	Published - 2019
Event	Gastrointestinal Cancers Symposium - San Francisco, CA Duration: 17 Jan 2019 → 19 Jan 2019

Access to Document

10.1200/JCO.2019.37.4_suppl.480

Cite this

Schimanski, CC., Kasper, S., Hegewisch-Becker, S., Schroeder, J., Overkamp, F., Kullmann, F., Bechstein, WO., Vohringer, M., Oellinger, R., Lordick, F., Heinemann, V., Geissler, M., Schulz-Abelius, A., Linz, B., Bernhard, H., Schoen, MR., Greil, R., Smith-Machnow, V., Schmidtmann, I., & Moehler, MH. (2019). A randomized, double-blinded, placebo-controlled multicenter phase II trial of adjuvant immunotherapy with tecemotide (L-BLP25) after R0/R1 hepatic colorectal cancer metastasectomy (LICC): Final results. JOURNAL OF CLINICAL ONCOLOGY , 37(4). https://doi.org/10.1200/JCO.2019.37.4_suppl.480

Schimanski, CC ; Kasper, S ; Hegewisch-Becker, S et al. / A randomized, double-blinded, placebo-controlled multicenter phase II trial of adjuvant immunotherapy with tecemotide (L-BLP25) after R0/R1 hepatic colorectal cancer metastasectomy (LICC): Final results. In: JOURNAL OF CLINICAL ONCOLOGY 2019 ; Vol. 37, No. 4.

@article{d4d875a4ff1d44ff8bc361fe49e1e717,

title = "A randomized, double-blinded, placebo-controlled multicenter phase II trial of adjuvant immunotherapy with tecemotide (L-BLP25) after R0/R1 hepatic colorectal cancer metastasectomy (LICC): Final results.",

author = "CC Schimanski and S Kasper and S Hegewisch-Becker and J Schroeder and F Overkamp and F Kullmann and WO Bechstein and M Vohringer and R Oellinger and F Lordick and V Heinemann and M Geissler and A Schulz-Abelius and B Linz and H Bernhard and MR Schoen and Richard Greil and V Smith-Machnow and I Schmidtmann and MH Moehler",

year = "2019",

doi = "10.1200/JCO.2019.37.4_suppl.480",

language = "English",

volume = "37",

journal = "JOURNAL OF CLINICAL ONCOLOGY ",

issn = "0732-183X",

publisher = "Lippincott Williams & Wilkins ",

number = "4",

note = "Gastrointestinal Cancers Symposium ; Conference date: 17-01-2019 Through 19-01-2019",

}

Schimanski, CC, Kasper, S, Hegewisch-Becker, S, Schroeder, J, Overkamp, F, Kullmann, F, Bechstein, WO, Vohringer, M, Oellinger, R, Lordick, F, Heinemann, V, Geissler, M, Schulz-Abelius, A, Linz, B, Bernhard, H, Schoen, MR, Greil, R, Smith-Machnow, V, Schmidtmann, I & Moehler, MH 2019, 'A randomized, double-blinded, placebo-controlled multicenter phase II trial of adjuvant immunotherapy with tecemotide (L-BLP25) after R0/R1 hepatic colorectal cancer metastasectomy (LICC): Final results.', JOURNAL OF CLINICAL ONCOLOGY , vol. 37, no. 4. https://doi.org/10.1200/JCO.2019.37.4_suppl.480

A randomized, double-blinded, placebo-controlled multicenter phase II trial of adjuvant immunotherapy with tecemotide (L-BLP25) after R0/R1 hepatic colorectal cancer metastasectomy (LICC): Final results. / Schimanski, CC; Kasper, S; Hegewisch-Becker, S et al.
In: JOURNAL OF CLINICAL ONCOLOGY , Vol. 37, No. 4, 2019.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - A randomized, double-blinded, placebo-controlled multicenter phase II trial of adjuvant immunotherapy with tecemotide (L-BLP25) after R0/R1 hepatic colorectal cancer metastasectomy (LICC): Final results.

AU - Schimanski, CC

AU - Kasper, S

AU - Hegewisch-Becker, S

AU - Schroeder, J

AU - Overkamp, F

AU - Kullmann, F

AU - Bechstein, WO

AU - Vohringer, M

AU - Oellinger, R

AU - Lordick, F

AU - Heinemann, V

AU - Geissler, M

AU - Schulz-Abelius, A

AU - Linz, B

AU - Bernhard, H

AU - Schoen, MR

AU - Greil, Richard

AU - Smith-Machnow, V

AU - Schmidtmann, I

AU - Moehler, MH

PY - 2019

Y1 - 2019

U2 - 10.1200/JCO.2019.37.4_suppl.480

DO - 10.1200/JCO.2019.37.4_suppl.480

M3 - Abstract (Journal)

SN - 0732-183X

VL - 37

JO - JOURNAL OF CLINICAL ONCOLOGY

JF - JOURNAL OF CLINICAL ONCOLOGY

IS - 4

T2 - Gastrointestinal Cancers Symposium

Y2 - 17 January 2019 through 19 January 2019

ER -

Schimanski CC, Kasper S, Hegewisch-Becker S, Schroeder J, Overkamp F, Kullmann F et al. A randomized, double-blinded, placebo-controlled multicenter phase II trial of adjuvant immunotherapy with tecemotide (L-BLP25) after R0/R1 hepatic colorectal cancer metastasectomy (LICC): Final results. JOURNAL OF CLINICAL ONCOLOGY . 2019;37(4). doi: 10.1200/JCO.2019.37.4_suppl.480